
Celeste A. Roney
Examiner (ID: 19047, Phone: (571)272-5192 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 873 |
| Issued Applications | 472 |
| Pending Applications | 148 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19225435
[patent_doc_number] => 12005065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Corticotropin releasing factor receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 18/307718
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 21534
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307718 | Corticotropin releasing factor receptor antagonists | Apr 25, 2023 | Issued |
Array
(
[id] => 19225435
[patent_doc_number] => 12005065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Corticotropin releasing factor receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 18/307718
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 21534
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307718 | Corticotropin releasing factor receptor antagonists | Apr 25, 2023 | Issued |
Array
(
[id] => 19225435
[patent_doc_number] => 12005065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Corticotropin releasing factor receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 18/307718
[patent_app_country] => US
[patent_app_date] => 2023-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 21534
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18307718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/307718 | Corticotropin releasing factor receptor antagonists | Apr 25, 2023 | Issued |
Array
(
[id] => 19903142
[patent_doc_number] => 12280126
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-22
[patent_title] => Deodorant including at least one fruit acid and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 18/138774
[patent_app_country] => US
[patent_app_date] => 2023-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 1397
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18138774
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/138774 | Deodorant including at least one fruit acid and methods of using the same | Apr 24, 2023 | Issued |
Array
(
[id] => 18707451
[patent_doc_number] => 20230330025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => Particle Modifiers for Multi-Drug Loaded Nanoparticles
[patent_app_type] => utility
[patent_app_number] => 18/301661
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301661 | Particle Modifiers for Multi-Drug Loaded Nanoparticles | Apr 16, 2023 | Pending |
Array
(
[id] => 18692336
[patent_doc_number] => 20230322566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PURIFICATION OF CLINOPTILOLITE
[patent_app_type] => utility
[patent_app_number] => 18/135286
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18135286
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/135286 | Purification of clinoptilolite | Apr 16, 2023 | Issued |
Array
(
[id] => 18707562
[patent_doc_number] => 20230330138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/300233
[patent_app_country] => US
[patent_app_date] => 2023-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18300233
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/300233 | TREATMENT OF CARTILAGE DEGENERATION USING MYELOID SUPPRESSOR CELLS AND EXOSOMES DERIVED THEREOF | Apr 12, 2023 | Abandoned |
Array
(
[id] => 20465292
[patent_doc_number] => 12521321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-13
[patent_title] => Oral care compositions comprising fluoride
[patent_app_type] => utility
[patent_app_number] => 18/130092
[patent_app_country] => US
[patent_app_date] => 2023-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18433
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18130092
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/130092 | Oral care compositions comprising fluoride | Apr 2, 2023 | Issued |
Array
(
[id] => 20644648
[patent_doc_number] => 12599573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-14
[patent_title] => Compositions and uses thereof in treating cancers
[patent_app_type] => utility
[patent_app_number] => 18/185630
[patent_app_country] => US
[patent_app_date] => 2023-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 4
[patent_no_of_words] => 3261
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18185630
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/185630 | COMPOSITIONS AND USES THEREOF IN TREATING CANCERS | Mar 16, 2023 | Issued |
Array
(
[id] => 18483691
[patent_doc_number] => 20230210993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => LIPID COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/182733
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 462
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18182733
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/182733 | LIPID COMPOSITION | Mar 12, 2023 | Pending |
Array
(
[id] => 20262934
[patent_doc_number] => 12433902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation
[patent_app_type] => utility
[patent_app_number] => 18/120770
[patent_app_country] => US
[patent_app_date] => 2023-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16808
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18120770
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/120770 | Liposomal formulations for inhibiting SARS-CoV-2 replication and reducing lung inflammation | Mar 12, 2023 | Issued |
Array
(
[id] => 19185464
[patent_doc_number] => 20240164377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => LOW VOLATILITY PROMOTING WATER CONDITIONING ADJUVANTS
[patent_app_type] => utility
[patent_app_number] => 18/180656
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180656 | LOW VOLATILITY PROMOTING WATER CONDITIONING ADJUVANTS | Mar 7, 2023 | Abandoned |
Array
(
[id] => 18510092
[patent_doc_number] => 20230226192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => IONIZABLE LIPIDS AND COMPOSITIONS FOR NUCLEIC ACID DELIVERY
[patent_app_type] => utility
[patent_app_number] => 18/117049
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13256
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18117049
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/117049 | Ionizable lipids and compositions for nucleic acid delivery | Mar 2, 2023 | Issued |
Array
(
[id] => 18536004
[patent_doc_number] => 20230241091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => COMPOSITIONS FOR USE IN THE TREATMENT AND PREVENTION OF CARDIOVASCULAR DISORDERS RESULTING FROM CEREBROVASCULAR INJURY
[patent_app_type] => utility
[patent_app_number] => 18/173980
[patent_app_country] => US
[patent_app_date] => 2023-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173980
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173980 | Compositions for use in the treatment and prevention of cardiovascular disorders resulting from cerebrovascular injury | Feb 23, 2023 | Issued |
| 18/041891 | LIPID DELIVERY SYSTEMS FOR DELIVERY OF OXALIPLATIN PALMITATE ACETATE | Feb 15, 2023 | Abandoned |
Array
(
[id] => 19359217
[patent_doc_number] => 20240261251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Composition for Liposomal Delivery of Supplemental Urolithin
[patent_app_type] => utility
[patent_app_number] => 18/166335
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3770
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/166335 | Composition for Liposomal Delivery of Supplemental Urolithin | Feb 7, 2023 | Pending |
Array
(
[id] => 18434185
[patent_doc_number] => 20230181479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => POLYMER BASED FORMULATION FOR RELEASE OF DRUGS AND BIOACTIVES AT SPECIFIC GIT SITES
[patent_app_type] => utility
[patent_app_number] => 18/164174
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18164174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/164174 | POLYMER BASED FORMULATION FOR RELEASE OF DRUGS AND BIOACTIVES AT SPECIFIC GIT SITES | Feb 2, 2023 | Abandoned |
Array
(
[id] => 18550850
[patent_doc_number] => 20230248850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => GOLD MOLECULAR CLUSTERS AND METHODS OF USING SAME FOR NEAR-INFRARED IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/102623
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102623
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102623 | GOLD MOLECULAR CLUSTERS AND METHODS OF USING SAME FOR NEAR-INFRARED IMAGING | Jan 26, 2023 | Pending |
Array
(
[id] => 19372972
[patent_doc_number] => 12064511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy
[patent_app_type] => utility
[patent_app_number] => 18/159010
[patent_app_country] => US
[patent_app_date] => 2023-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 9284
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159010 | Lipid nanoparticles containing silyl lipids for use in vaccines and gene therapy | Jan 23, 2023 | Issued |
Array
(
[id] => 19246607
[patent_doc_number] => 20240197591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR
[patent_app_type] => utility
[patent_app_number] => 18/084403
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18084403
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/084403 | COMPOSITIONS AND METHODS FOR REMOVING COLOR FROM HAIR | Dec 18, 2022 | Pending |